Trade Protagonist Therapeutics Inc - PTGX CFD

Trading Conditions

• Type: CFD
• Spread: 0.17
• Long position overnight funding adjustment: -0.02154%
• Short position overnight funding adjustment: -0.00068%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 0.1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 104.1
• Open: 101.98
• 1-Year Change: 99.65%
• Day's Range: 101.45 - 105.28

What is Protagonist Therapeutics Inc (PTGX)?

Protagonist Therapeutics Inc is a biopharmaceutical company focused on the development of oral peptide therapies for patients with serious diseases. The company specializes in discovering and developing novel medicines that target specific receptors involved in disease pathways, particularly in the areas of inflammation, oncology, and metabolic disorders. Utilizing its proprietary peptide technology platform, Protagonist Therapeutics aims to create treatments that offer improved efficacy and safety profiles compared to existing therapies. The company’s pipeline includes multiple clinical and preclinical candidates addressing conditions such as inflammatory bowel disease, cancer, and other immune-related disorders. Protagonist Therapeutics collaborates with academic institutions and industry partners to advance its research and development efforts. Its operations encompass drug discovery, clinical development, and regulatory activities, with a focus on translating scientific insights into therapeutic solutions. The company is headquartered in the United States and contributes to the broader biopharmaceutical landscape through innovation in peptide-based drug development.

Protagonist Therapeutics Inc Stock Price Today: Live Overview

The price today is shaped by ongoing trades, with Protagonist Therapeutics Inc valued at $102.25. During the session, prices have moved between $101.23 and $105.44, marked by a daily percentage change of -2.2405%.

FAQ: Protagonist Therapeutics Inc (PTGX)

What is the current price of PTGX stock?

The current price is $102.25.

Does PTGX pay dividends?

No dividends are paid by the company.

Does PTGX have a formal corporate presence or regional headquarters in the UAE?

Protagonist Therapeutics Inc does not have an official office or subsidiary in the UAE and operates through local partners.

What is PTGX best known for?

The company is most famous for its development of peptide-based therapies.

What assets are typically shown together with PTGX?

Commonly shown alongside PTGX: Safestore, Expedia, Norwegian